Matthew W. Cartwright

Discovery of Novel PI3-Kinase δ Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition

Brian S. Safina, Stewart Baker, Matt Baumgardner et al. · Journal of Medicinal Chemistry · 2012 · 66 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Dipyrido[1,2-a;3′,4′-d]imidazole systems

Matthew W. Cartwright, L. Convery, T. Kraynck et al. · Tetrahedron · 2009 · 47 citations · Full text

Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)

Bryan Chan, Eileen M. Seward, Michael Lainchbury et al. · ACS Medicinal Chemistry Letters · 2021 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

The (in)complete organelle genome: exploring the use and nonuse of available technologies for characterizing mitochondrial and plastid chromosomes

Matheus Sanitá Lima, Laura C. Woods, Matthew W. Cartwright et al. · Molecular Ecology Resources · 2016 · 40 citations · Full text

Life Sciences, Biology, Genetics +15

A reversed sulfonamide series of selective RORc inverse agonists

Monique B. van Niel, Benjamin P. Fauber, Matthew W. Cartwright et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +6